Genomic and Immunophenotypic Landscape of Acquired Resistance to PD-(L)1 Blockade in Non–Small-Cell Lung Cancer

Biagio Ricciuti(Harvard University), Mark M. Awad(Memorial Sloan Kettering Cancer Center), Adriana Barrichello(Dana-Farber Cancer Institute), Federica Pecci(University of Parma), Sandro Santagata(Harvard University), Jason L. Weirather(Dana-Farber Cancer Institute), Deepti Venkatraman(Dana-Farber Cancer Institute), Andrew D. Cherniack(Broad Institute), Danielle Haradon(Dana-Farber Cancer Institute), Yvonne Y. Li(Broad Institute), Victor R. Vaz(Dana-Farber Cancer Institute), Elinton Lee(Dana-Farber Cancer Institute), Liam F. Spurr(Broad Institute), Bruce E. Johnson(Harvard University), Jia‐Ren Lin(Harvard University), Andy Pangilinan(Dana-Farber Cancer Institute), Scott J. Rodig(Brigham and Women's Hospital), Peter K. Sorger(Harvard University Press), Mizuki Nishino(Brigham and Women's Hospital), Hersh Gupta(Dana-Farber Cancer Institute), Alessandro Di Federico(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Ian Dryg(NYU Langone Health), Kathleen L. Pfaff(Dana-Farber Cancer Institute), Alexander Chowdhury(Dana-Farber Cancer Institute), Malini Gandhi(Dana-Farber Cancer Institute), Giuseppe Lamberti(Dana-Farber Cancer Institute), Joao V. Alessi(Hospital Sírio-Libanês), Navin R. Mahadevan(Brigham and Women's Hospital), Lynette M. Sholl(Brigham and Women's Hospital), Renato Umeton(Harvard University), Emma L. Welsh(Brigham and Women's Hospital), Sreekar Reddy Puchala(Dana-Farber Cancer Institute), Xinan Wang(Harvard University)
Journal of Clinical Oncology
January 11, 2024
Cited by 124


Related Papers